Biotech entity

MedTech

Technology

Department of Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 139-day span. Each story carries 2 original sources on average, compared with 4 for the broader beat in this window.

Last mentioned: Aug 7, 2026

Entity pulse

Recent coverage · MedTech

2 stories
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about MedTech

Department of Pharmaceuticals is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 0.1 stories per week across a 139-day span. Each story carries 2 original sources on average, compared with 4 for the broader beat in this window. Coverage clusters in fda-approval, which accounts for 1 of those 2, with the remainder spread across 1 other category. The 7 average consequence score is above the beat benchmark of 6.3 in the same window. This profile follows 2 Biotech stories mentioning MedTech across the period from March 22, 2026 to August 7, 2026.

Stories tracked
2
Per week
0.1
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 290 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering MedTech. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning MedTech 2

FDA Actions Positive

Bio-Pharma Opportunity: India's MedTech Meet Eyes $600B Global Pie

The 9th India Medical Device 2026 conference offers biotech and pharma companies a clear signal to diversify into the device sector, as the government pushes for domestic manufacturing and innovation. Regulatory sentiment is shifting to support local production, opening new market adjacencies.

2 sources
Pharma Positive

India's Pharma and MedTech Surge Signals Shift to Healthcare Self-Reliance

Union Minister Jitendra Singh has highlighted a significant boom in India's pharmaceutical and medical technology sectors, marking a strategic pivot toward national self-reliance. This growth reflects a broader movement to reduce import dependency and establish India as a global manufacturing hub for advanced medical solutions.

2 sources

MedTech is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.